Video Interview

CenExel AMRI’s Dr. Singh

interviewed by Daytime Buffalo

Get instant access

Dr. Arun Singh, Principal Investigator at CenExel Toms River, joined Daytime Buffalo to discuss what’s next in Alzheimer’s prevention and care. He highlighted how recent clinical trials have driven major breakthroughs—leading to newly approved treatments like Kisunla and Leqembi—and emphasized the crucial role research plays in early detection and limited-treatment environments. Dr. Singh also explained how CenExel ensures high patient engagement through transparent communication and supportive, personalized care, while exploring emerging strategies such as gene therapy and immunotherapy that may shape the next generation of Alzheimer’s treatments. He closed with practical, research-backed lifestyle tips to support brain health, offering viewers actionable ways to reduce cognitive decline as scientific advances continue to accelerate.